Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zometa for Osteoporosis Prevention in Prostate Cancer
NCT00329797Phase 3Completed
- Sponsor
- NRG Oncology
- Start
- Mar 2006
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of zoledronic acid in osteoporosis, sponsored by NRG Oncology. Started Mar 2006; status: completed.
02
Drugs
zoledronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00329797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00329797.